(108) found the problem of high expression of BCL-W in B-cell lymphoma and proposed some clinical methods to inhibit anti-apoptotic BCL-2, making outstanding contributions to the exploration of how to treat B-cell lymphoma (109). This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.